Pharmacologic therapy for human immunodeficiency virus infection: a review.
Neuzil
K M
KM
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2005.
D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine / Q000627:therapeutic use / Q000633:toxicity; D013329:Structure-Activity Relationship; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D018119:Stavudine; D016049:Didanosine